Literature DB >> 5319840

Nitrofurazone as a mutagen in Escherichia coli.

A Zampieri, J Greenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1964        PMID： 5319840     DOI： 10.1016/0006-291x(64)90249-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  8 in total

1.  Cell division and prophage induction in Escherichia coli: effects of pantoyl lactone and various furan derivatives.

Authors:  E P Kirby; W L Ruff; D A Goldthwait
Journal:  J Bacteriol       Date:  1972-08       Impact factor: 3.490

Review 2.  [On possible mutagenic side effects of drugs in man].

Authors:  G Röhrborn
Journal:  Humangenetik       Date:  1965

3.  Sister chromatid exchanges in peripheral lymphocytes of urinary tract infection treated with nitrofurantoin.

Authors:  S Sardaş; A Metin; S Gök; A E Karakaya; N Aykol
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

4.  Mutagenic action of nitrofurans on Euglena gracilis and Mycobacterium phlei.

Authors:  L Ebringer; A Jurásek; J Konicek; M Konícková; N Lahitová; S Trubacík
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

5.  Mutagenicity of nitrofuran drugs in bacterial systems.

Authors:  L Ebringer; M Bencová
Journal:  Folia Microbiol (Praha)       Date:  1980       Impact factor: 2.099

6.  Mode of action of nitrofurazone.

Authors:  D R McCalla; A Reuvers; C Kaiser
Journal:  J Bacteriol       Date:  1970-12       Impact factor: 3.490

7.  Nucleotide excision repair is a predominant mechanism for processing nitrofurazone-induced DNA damage in Escherichia coli.

Authors:  Katherine R Ona; Charmain T Courcelle; Justin Courcelle
Journal:  J Bacteriol       Date:  2009-05-22       Impact factor: 3.490

8.  A chemical genetics analysis of the roles of bypass polymerase DinB and DNA repair protein AlkB in processing N2-alkylguanine lesions in vivo.

Authors:  Nidhi Shrivastav; Bogdan I Fedeles; Deyu Li; James C Delaney; Lauren E Frick; James J Foti; Graham C Walker; John M Essigmann
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.